Oxygen Biotherapeutics Mission & Goals

News & Events

Oxygen Biotherapeutics Inc., Announces the Appointment of Industry Veteran Gerald Proehl to its Board of Directors


Friday, April 4, 2014 5:00 am PDT
Dateline:
MORRISVILLE, N.C.

Public Company Information:
NASDAQ:OXBTUS69207P2092


MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that it has appointed Gerald Proehl, former President and CEO of Santarus, Inc. as a member of the company’s Board of Directors. Mr. Proehl’s addition is a new position on the company’s Board. more..

Quick Links

About Oxygen Biotherapeutics Mission

The Mission of Oxygen Biotherapeutics is to develop and market specialty pharmaceutical products that address unmet needs of critical care patients, their health care providers, and the hospitals who treat these patients.